Vagus nerve stimulation for depression: efficacy and safety in a European study
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Vagus nerve stimulation (VNS) therapy is associated with a decrease in seizure frequency in partial-onset seizure patients. Initial trials suggest that it may be an effective treatment, with few side-effects, for intractable depression. Method: An open, uncontrolled European multi-centre study (D03) of VNS therapy was conducted, in addition to stable pharmacotherapy, in 74 patients with treatment-resistant depression (TRD). Treatment remained unchanged for the first 3 months; in the subsequent 9 months, medications and VNS dosing parameters were altered as indicated clinically. Results: The baseline 28-item Hamilton Depression Rating Scale (HAMD-28) score averaged 34. After 3 months of VNS, response rates (⩾50% reduction in baseline scores) reached 37% and remission rates (HAMD-28 score <10) 17%. Response rates increased to 53% after 1 year of VNS, and remission rates reached 33%. Response was defined as sustained if no relapse occurred during the first year of VNS after response onset; 44% of patients met these criteria. Median time to response was 9 months. Most frequent side-effects were voice alteration (63% at 3 months of stimulation) and coughing (23%). Conclusions: VNS therapy was effective in reducing severity of depression; efficacy increased over time. Efficacy ratings were in the same range as those previously reported from a USA study using a similar protocol; at 12 months, reduction of symptom severity was significantly higher in the European sample. This might be explained by a small but significant difference in the baseline HAMD-28 score and the lower number of treatments in the current episode in the European study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of VNS over a period of 3 months resulted in a response rate of 37% and a remission rate of 17%. After 1 year of treatment, the response rate reached 53% and the remission rate reached 33%.”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [113]
In the citing paper
“A European multicenter study demonstrated a positive effect of VNS on depressive symptoms, in patients with treatment-resistant depression (113).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [113]
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410 · cited 2×
“This protocol was very similar to the D01 study conducted in the USA, except that (1) study inclusion required a score o20 on the HAMD-24 (Hamilton, 1967) in the D03 study, as opposed to o20 on the 28-item HAMD (HAMD-28) in the D01 study, (2) the maximum age at entry was 80 in the D03 study and 70…”
ResultRush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial
Handforth, A., DeGiorgio, C. M., Schachter, S. C., Uthman, B. M., Naritoku, D. K., Tecoma, E. S., Henry, T. R., Collins, S. D., Vaughn, B. V., Gilmartin, R. C., et al. (1998) · Neurology · doi:10.1212/wnl.51.1.48 · Cited by 1,107
Keller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864 · cited 1×
“Keller et al. (1992) studied the course of depression treatment prospectively over a 5-year period and found that the recovery rate decreased over time.”
BackgroundLong-term treatment with vagus nerve stimulation in patients with refractory epilepsy
Morris, G. L., Mueller, W. M., & The Vagus Nerve Stimulation Study Group E–E (1999) · Neurology · doi:10.1212/wnl.53.8.1731 · Cited by 724 · cited 1×
“…in patients with treatment-resistant epilepsy and has been demonstrated to be effective in reducing seizure frequency (Ben-Menachem et al. 1994; The Vagus Nerve Stimulation Study Group, 1995 ; Handforth et al. 1998 ; Morris & Mueller, 1999 ; Uthman, 2000 ; Ben-Menachem, 2001; Schachter, 2002).”
BackgroundRush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688 · cited 12×
“While in the first 3 months of VNS therapy output current in the D01 study ranged from 0.25 to 3.00 mA (mean 0.96¡0.54 mA) (Sackeim et al. 2001), in the D02 study output current ranged from 0.25 to 3.00 mA (mean 0.67¡0.33 mA) (Rush et al. 2005a).”
BackgroundResultInfluentialBen‐Menachem, E., Mañon‐Espaillat, R., Ristanovic, R., Wilder, B. J., Stefan, H., Mirza, W., Tarver, W. B., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02482.x · Cited by 683
Groves, D. A., & Brown, V. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.01.004 · Cited by 675
(1995) · Neurology · doi:10.1212/wnl.45.2.224 · Cited by 674 · cited 2×
“…in patients with treatment-resistant epilepsy and has been demonstrated to be effective in reducing seizure frequency (Ben-Menachem et al. 1994; The Vagus Nerve Stimulation Study Group, 1995 ; Handforth et al. 1998 ; Morris & Mueller, 1999 ; Uthman, 2000 ; Ben-Menachem, 2001; Schachter, 2002).”
BackgroundSackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Research works printed but not linked: 2
- 10.1016/j.biopsych.2005.05.025 · DOI · Paper page
- 1995, COSTART: Coding Symbols for Thesaurus of Adverse Reaction Terms
Cited by
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“vNS in Depression A European multicenter study demonstrated a positive effect of VNS on depressive symptoms, in patients with treatment-resistant depression (113).”
BackgroundBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“…of 1,855 patients from one systematic review (Daban et al. 2008), two randomized controlled trials (Nahas et al. 2007; Nierenberg et al. 2008), one non-randomized controlled trial (Sperling et al. 2009), and three case series (Sackeim et al. 2007; Franzini et al. 2008; Schlaepfer et al. 2008).”
BackgroundMilev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., Modirrousta, M., Patry, S., Vila-Rodriguez, F., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660033 · Cited by 586
“The median time to response with VNS was estimated to be 9 months in 1 study.(84) In another VNS study (N 1⁄4 74), only 35% of patients had achieved a response by 3 months, but 61.”
MethodParikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Metadata
- Authors
- Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., Rau, H., Hoff, H.-J., Padberg, F., Müller-Siecheneder, F., Audenaert, K., Van den Abbeele, D., Matthews, K., Christmas, D., Stanga, Z., & Hasdemir, M.
- Affiliations
- Johns Hopkins University (US)
- University Hospital Bonn (DE)
- Freie Universität Berlin (DE)
- Beaumont Hospital (IE)
- University Hospital of Umeå (SE)
- National Hospital for Neurology and Neurosurgery (GB)
- Evangelisches Krankenhaus Bielefeld (DE)
- Ludwig-Maximilians-Universität München (DE)
- Ghent University Hospital (BE)
- Ninewells Hospital (GB)
- University Hospital of Bern (CH)
- Lindenhofspital (CH)
- Corresponding author
- Schlaepfer, T. E.
- ORCID
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-01-04
- Volume
- 38
- Issue
- 5
- Pages
- 651-661
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2086712277
- Cited by
- 205
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 13 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 7 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 7 · 2015: 15 · 2014: 11 · 2013: 16 · 2012: 18
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Open Access CRIS of the University of Bern
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- vagus nerve stimulation, treatment-resistant depression, antidepressant efficacy, remission rate, adverse effects, voice change, cough, pharmacotherapy, open-label extension, European patients
- MeSH terms
- Adult, Anticonvulsants, Antidepressive Agents, Bipolar Disorder, Combined Modality Therapy, Major Depressive Disorder, Electric Stimulation Therapy, Europe, Female, Follow-Up Studies, Humans, Male, Middle Aged, Personality Inventory, Safety, Vagus Nerve, Treatment Outcome, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vagus nerve stimulation for depression: efficacy and safety in a European study. https://app.cochat.ai/papers/10.1017/s0033291707001924
- The paper
- Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., Rau, H., Hoff, H.-J., Padberg, F., Müller-Siecheneder, F., Audenaert, K., Van den Abbeele, D., Matthews, K., Christmas, D., Stanga, Z., & Hasdemir, M. (2008). Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine. https://doi.org/10.1017/s0033291707001924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.